Partial Redemption of Unsecured Loan Notes
EPE Special Opportunities Limited
31 July 2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT
31 July 2026
EPE Special Opportunities Ltd
Partial Redemption of Unsecured Loan Notes
EPE Special Opportunities Ltd ("ESO" or the "Company") announces that, following the amendment and extension of its outstanding Unsecured Loan Notes (the "Notes") constituted by the loan note instrument dated 23 July 2015 (as amended by a deed of amendment on 21 July 2022, a deed of amendment on 17 July 2024 and a deed of amendment on 21 July 2026) (the "Loan Note Instrument"), the Company redeemed £1,726,428 in aggregate principal amount of Notes pursuant to the Special Redemption Option on 31 July 2026. The redeemed Notes have been or will be cancelled.
Enquiries:
|
EPIC Investment Partners LLP |
+44 (0) 207 269 8860 Rupert Palmer |
|
Langham Hall Fund Management (Jersey) Limited |
+44 (0) 153 488 5200 Amanda Robinson |
|
|
|
|
Cardew Group Limited |
+44 (0) 207 930 0777 Richard Spiegelberg |
|
|
|
|
Deutsche Numis |
+44 (0) 207 260 1000 |
|
Nominated Advisor/Corporate Advisor: |
Stuart Skinner |
|
Corporate Broker: |
Charles Farquhar |
Company Information:
EPE Special Opportunities Ltd
Incorporated in Bermuda
Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda
Company Number: 53954
ISIN: GB00BF0XD821
AQSE Growth Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.